Acetaminophen and Diphenhydramine Premedication for Allergic and Febrile Nonhemolytic Transfusion Reactions: Good Prophylaxis or Bad Practice?

Transfusion Medicine Reviews

Volumn 21, Issue 1, 2007, Pages 1-12

  Geiger, Terrence L ^a   Howard, Scott C ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CORTICOSTEROID; CYTOKINE; DIPHENHYDRAMINE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INFUSION FLUID; LEUKOAGGLUTININ; PARACETAMOL;

ALERTNESS; ALLERGIC REACTION; ARTICLE; BLOOD COMPONENT THERAPY; BLOOD TRANSFUSION REACTION; CARDIOTOXICITY; CLINICAL FEATURE; CLINICAL STUDY; CLINICAL TRIAL; COGNITIVE DEFECT; COST BENEFIT ANALYSIS; DROWSINESS; DRUG COST; DRUG EFFICACY; DRUG MECHANISM; ERYTHROCYTE; FEBRILE NONHEMOLYTIC REACTION; HEART ARRHYTHMIA; HUMAN; INJURY; LIVER TOXICITY; MORBIDITY; NERVOUSNESS; PATHOPHYSIOLOGY; PHYSICIAN; PRESCRIPTION; PREVALENCE; PROPHYLAXIS; RECOMMENDED DRUG DOSE; RESTLESSNESS; RISK FACTOR; SIDE EFFECT; THROMBOCYTE; UNITED STATES;

ACETAMINOPHEN; ANALGESICS, NON-NARCOTIC; ANTI-ALLERGIC AGENTS; BLOOD COMPONENT TRANSFUSION; DIPHENHYDRAMINE; FEVER; HUMANS; HYPERSENSITIVITY;

EID: 33845323372     PISSN: 08877963     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tmrv.2006.09.001     Document Type: Article

References (63)

1. Ezidiegwu C.N., Lauenstein K.J., Rosales L.G., et al. Febrile nonhemolytic transfusion reactions. Management by premedication and cost implications in adult patients. Arch Pathol Lab Med 128 (2004) 991-995
2. Patterson B.J., Freedman J., Blanchette V., et al. Effect of premedication guidelines and leukoreduction on the rate of febrile nonhaemolytic platelet transfusion reactions. Transfus Med 10 (2000) 199-206
3. Sanders R.P., Maddirala S.D., Geiger T.L., et al. Premedication with acetaminophen or diphenhydramine for transfusion with leucoreduced blood products in children. Br J Haematol 130 (2005) 781-787
4. Yazer M.H., Podlosky L., Clarke G., et al. The effect of prestorage WBC reduction on the rates of febrile nonhemolytic transfusion reactions to platelet concentrates and RBC. Transfusion 44 (2004) 10-15
5. Paglino J.C., Pomper G.J., Fisch G.S., et al. Reduction of febrile but not allergic reactions to RBCs and platelets after conversion to universal prestorage leukoreduction. Transfusion 44 (2004) 16-24
6. King K.E., Shirey R.S., Thoman S.K., et al. Universal leukoreduction decreases the incidence of febrile nonhemolytic transfusion reactions to RBCs. Transfusion 44 (2004) 25-29
7. Ibojie J., Greiss M., and Urbaniak S.J. Limited efficacy of universal leucodepletion in reducing the incidence of febrile non-haemolytic reactions in red cell transfusion. Transfus Med 12 (2002) 387-389
8. Pitocco C., and Sexton T.R. Alleviating blood shortages in a resource-constrained environment. Transfusion 45 (2005) 1118-1126
9. Sullivan M.T., and Wallace E.L. Blood collection and transfusion in the United States in 1999. Transfusion 45 (2005) 141-148
10. Heddle N.M. Pathophysiology of febrile nonhemolytic transfusion reactions. Curr Opin Hematol 6 (1999) 420-426
11. Stack G., and Snyder E.L. Cytokine generation in stored platelet concentrates. Transfusion 34 (1994) 20-25
12. Heddle N.M., Klama L., Singer J., et al. The role of the plasma from platelet concentrates in transfusion reactions. N Engl J Med 331 (1994) 625-628
13. Muylle L., Laekeman G., Herman A.G., et al. Histamine levels in stored platelet concentrates. Relationship to white cell content. Transfusion 28 (1988) 226-228
14. Stack G., Baril L., Napychank P., et al. Cytokine generation in stored, white cell-reduced, and bacterially contaminated units of red cells. Transfusion 35 (1995) 199-203
15. Wadhwa M., Seghatchian M.J., Dilger P., et al. Cytokines in WBC-reduced apheresis PCs during storage: A comparison of two WBC-reduction methods. Transfusion 40 (2000) 1118-1126
16. Schleuning M., Bock M., and Mempel W. Complement activation during storage of single-donor platelet concentrates. Vox Sang 67 (1994) 144-148
17. Gyongyossy-Issa M.I., McLeod E., and Devine D.V. Complement activation in platelet concentrates is surface-dependent and modulated by the platelets. J Lab Clin Med 123 (1994) 859-868
18. Takahashi T.A., Abe H., Hosoda M., et al. Bradykinin generation during filtration of platelet concentrates with a white cell-reduction filter. Transfusion 35 (1995) 967
19. Brittingham T.E., and Chaplin Jr. H. Febrile transfusion reactions caused by sensitivity to donor leukocytes and platelets. JAMA 165 (1957) 819-825
20. de Rie M.A., van der Plas-van Dalen C.M., Engelfriet C.P., et al. The serology of febrile transfusion reactions. Vox Sang 49 (1985) 126-134
21. Domen R.E., and Hoeltge G.A. Allergic transfusion reactions: an evaluation of 273 consecutive reactions. Arch Pathol Lab Med 127 (2003) 316-320
22. Janeway Jr. C.A., Travers P., Walport M., et al. Immunobiology. 6 ed. (2005), Garland Science, New York
23. Hoffjan S., Nicolae D., and Ober C. Association studies for asthma and atopic diseases: A comprehensive review of the literature. Respir Res 4 (2003) 14
24. Gilstad C.W. Anaphylactic transfusion reactions. Curr Opin Hematol 10 (2003) 419-423
25. Lambin P., Le Pennec P.Y., Hauptmann G., et al. Adverse transfusion reactions associated with a precipitating anti-C4 antibody of anti-Rodgers specificity. Vox Sang 47 (1984) 242-249
26. Michel J., and Sharon R. Non-haemolytic adverse reaction after transfusion of a blood unit containing penicillin. BMJ 280 (1980) 152-153
27. Branch D.R., and Gifford H. Allergic reaction to transfused cephalothin antibody. JAMA 241 (1979) 495-496
28. Johansson S.G., Nopp A., van H.M., et al. Passive IgE-sensitization by blood transfusion. Allergy 60 (2005) 1192-1199
29. Metcalfe D.D., Baram D., and Mekori Y.A. Mast cells. Physiol Rev 77 (1997) 1033-1079
30. Dinarello C.A. Infection, fever, and exogenous and endogenous pyrogens: some concepts have changed. J Endotoxin Res 10 (2004) 201-222
31. Yamagata K., Matsumura K., Inoue W., et al. Coexpression of microsomal-type prostaglandin E synthase with cyclooxygenase-2 in brain endothelial cells of rats during endotoxin-induced fever. J Neurosci 21 (2001) 2669-2677
32. Mills E.M., Rusyniak D.E., and Sprague J.E. The role of the sympathetic nervous system and uncoupling proteins in the thermogenesis induced by 3,4-methylenedioxymethamphetamine. J Mol Med 82 (2004) 787-799
33. Blatteis C.M., Li S., Li Z., et al. Cytokines, PGE2 and endotoxic fever: A re-assessment. Prostaglandins Other Lipid Mediat 76 (2005) 1-18
34. Brunton L., Lazo J., and Parker K. Goodman & Gilman's the pharmacological basis of therapeutics. (11 ed.) (2005), McGraw-Hill, New York
35. Kaufman D.W., Kelly J.P., Rosenberg L., et al. Recent patterns of medication use in the ambulatory adult population of the United States: The Slone survey. JAMA 287 (2002) 337-344
36. Kaplowitz N. Acetaminophen hepatoxicity: What do we know, what don't we know, and what do we do next?. Hepatology 40 (2004) 23-26
37. Lee W.M. Acetaminophen and the U.S. Acute Liver Failure Study Group: Lowering the risks of hepatic failure. Hepatology 40 (2004) 6-9
38. Allmers H. Frequent acetaminophen use and allergic diseases: Is the association clear?. J Allergy Clin Immunol 116 (2005) 859-862
39. Casale T.B., Blaiss M.S., Gelfand E., et al. First do no harm: Managing antihistamine impairment in patients with allergic rhinitis. J Allergy Clin Immunol 111 (2003) S835-S842
40. Weiler J.M., Bloomfield J.R., Woodworth G.G., et al. Effects of fexofenadine, diphenhydramine, and alcohol on driving performance. A randomized, placebo-controlled trial in the Iowa driving simulator. Ann Intern Med 132 (2000) 354-363
41. Finkle W.D., Adams J.L., Greenland S., et al. Increased risk of serious injury following an initial prescription for diphenhydramine. Ann Allergy Asthma Immunol 89 (2002) 244-250
42. Sharma A.N., Hexdall A.H., Chang E.K., et al. Diphenhydramine-induced wide complex dysrhythmia responds to treatment with sodium bicarbonate. Am J Emerg Med 21 (2003) 212-215
43. Heddle N.M., Klama L.N., Griffith L., et al. A prospective study to identify the risk factors associated with acute reactions to platelet and red cell transfusions. Transfusion 33 (1993) 794-797
44. Wang S.E., Lara Jr. P.N., Lee-Ow A., et al. Acetaminophen and diphenhydramine as premedication for platelet transfusions: a prospective randomized double-blind placebo-controlled trial. Am J Hematol 70 (2002) 191-194
45. Buck S.A., Kickler T.S., McGuire M., et al. The utility of platelet washing using an automated procedure for severe platelet allergic reactions. Transfusion 27 (1987) 391-393
46. Perrotta P.L., and Snyder E.L. Non-infectious complications of transfusion therapy. Blood Rev 15 (2001) 69-83
47. Hinson J.A., Reid A.B., McCullough S.S., et al. Acetaminophen-induced hepatotoxicity: Role of metabolic activation, reactive oxygen/nitrogen species, and mitochondrial permeability transition. Drug Metab Rev 36 (2004) 805-822
48. Heubi J.E., Barbacci M.B., and Zimmerman H.J. Therapeutic misadventures with acetaminophen: Hepatoxicity after multiple doses in children. J Pediatr 132 (1998) 22-27
49. Verster J.C., Volkerts E.R., van Oosterwijck A.W., et al. Acute and subchronic effects of levocetirizine and diphenhydramine on memory functioning, psychomotor performance, and mood. J Allergy Clin Immunol 111 (2003) 623-627
50. O'Hanlon J.F., and Ramaekers J.G. Antihistamine effects on actual driving performance in a standard test: A summary of Dutch experience, 1989-94. Allergy 50 (1995) 234-242
51. Da Ponte P.A., Bidoli E., Talamini R., et al. Pre-storage leucocyte depletion and transfusion reaction rates in cancer patients. Transfus Med 15 (2005) 37-43
52. Couban S., Carruthers J., Andreou P., et al. Platelet transfusions in children: results of a randomized, prospective, crossover trial of plasma removal and a prospective audit of WBC reduction. Transfusion 42 (2002) 753-758
53. Heddle N.M., Blajchman M.A., Meyer R.M., et al. A randomized controlled trial comparing the frequency of acute reactions to plasma-removed platelets and prestorage WBC-reduced platelets. Transfusion 42 (2002) 556-566
54. Uhlmann E.J., Isgriggs E., Wallhermfechtel M., et al. Prestorage universal WBC reduction of RBC units does not affect the incidence of transfusion reactions. Transfusion 41 (2001) 997-1000
55. Sarkodee-Adoo C.B., Kendall J.M., Sridhara R., et al. The relationship between the duration of platelet storage and the development of transfusion reactions. Transfusion 38 (1998) 229-235
56. Riccardi D., Raspollini E., Rebulla P., et al. Relationship of the time of storage and transfusion reactions to platelet concentrates from buffy coats. Transfusion 37 (1997) 528-530
57. Anderson N.A., Gray S., Copplestone J.A., et al. A prospective randomized study of three types of platelet concentrates in patients with haematological malignancy: Corrected platelet count increments and frequency of nonhaemolytic febrile transfusion reactions. Transfus Med 7 (1997) 33-39
58. Muylle L., Wouters E., and Peetermans M.E. Febrile reactions to platelet transfusion: the effect of increased interleukin 6 levels in concentrates prepared by the platelet-rich plasma method. Transfusion 36 (1996) 886-890
59. Federowicz I., Barrett B.B., Andersen J.W., et al. Characterization of reactions after transfusion of cellular blood components that are white cell reduced before storage. Transfusion 36 (1996) 21-28
60. Dzieczkowski J.S., Barrett B.B., Nester D., et al. Characterization of reactions after exclusive transfusion of white cell-reduced cellular blood components. Transfusion 35 (1995) 20-25
61. Oksanen K., Ebeling F., Kekomaki R., et al. Adverse reactions to platelet transfusions are reduced by use of platelet concentrates derived from buffy coat. Vox Sang 67 (1994) 356-361
62. Mangano M.M., Chambers L.A., and Kruskall M.S. Limited efficacy of leukopoor platelets for prevention of febrile transfusion reactions. Am J Clin Pathol 95 (1991) 733-738
63. Chambers L.A., Kruskall M.S., Pacini D.G., et al. Febrile reactions after platelet transfusion: The effect of single versus multiple donors. Transfusion 30 (1990) 219-221